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Abstract
Background: Targeted temperature management in cardiac arrest was introduced following evidence of increased survival
from two controlled trials published in 2002. We wanted to investigate whether the introduction of targeted temperature
management to clinical practice had increased the survival of cardiac arrest patients at Haukeland University Hospital, Norway.
Methods:We included 336 unresponsive patients admitted to the emergency department between December 2003 and
December 2008 with return of spontaneous circulation following out-of-hospital cardiac arrest in the analysis. A propensity
score model was developed to evaluate the survival of patients receiving intensive care treatment including targeted
temperature management, compared with intensive care treatment not including targeted temperature management.
Results: Estimation of the treatment effect revealed an increase of 57 days (95% CI: 12–103, p = 0.01) in restricted mean
survival during the first year after cardiac arrest for intensive care treatment including targeted temperature management.
Discussion: As with all observational studies, bias is probable. However, propensity score methodology has been used in
order to reduce bias and establish causality. Although residual confounding is likely, our interpretation is that TTM increased
survival for comatose OHCA patients in our hospital because survival increased well beyond the level of significance.
Conclusion: The introduction of targeted temperature management to clinical practice is likely to have increased survival
for unresponsive patients following out-of-hospital cardiac arrest.
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Background
Targeted temperature management (TTM) at 32–34 degrees
Celsius (°C) following cardiac arrest (CA) was introduced to
clinical practice based on two controlled studies published in
2002, one randomised and one pseudorandomised [1, 2].
Both studies found that TTM improved survival and neuro-
logic function following CA compared with standard care. In
2011, a meta-analysis questioned the robustness of these
findings, and, 2 years later, a randomised controlled trial of
TTM at 33 °C compared to TTM at 36 °C was published [3,
4]. No difference in survival was found between the two
groups. A subgroup analysis published in 2015 found no
difference as regards the neurologic outcome in the same
two groups [5].
The cause of the discrepancy between these studies is not
known. It could be that TTM has no effect in clinical practice,
where the strict criteria of a randomised controlled study do
not apply. Another view is that improved intensive care treat-
ment over the past decade has removed the conditions for
which TTM had an effect. Perhaps TTM was of greater im-
portance when the attention to cerebral perfusion pressures,
body temperature and blood gas values was less stringent.
In order to shed light on this development, we decided
to analyse registry data from the introduction of TTM at
Haukeland University Hospital. This would allow us to
estimate the effects of TTM in clinical practice at a time
when intensive care treatment was similar to that in the
initial studies. Patients treated with TTM were compared
with those not treated with TTM. We applied propensity
score matching in order to generate comparable groups
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and establish causality. The primary objective was to test
the hypothesis that TTM improves survival after CA.
The secondary objective was to investigate the effect of
TTM on cognitive function in CA survivors.
Methods
Trial design
The study is a retrospective observational study from two in-
tensive care units at Haukeland University Hospital, Norway.
Patients
Epidemiology of CA in the Bergen area has previously been
described [6]. In December 2003, local guidelines were
introduced for the pre-hospital and in-hospital treatment of
CA survivors. New features in the guidelines included the
avoidance of fever, a more structured approach to intensive
care treatment and the introduction of TTM. The guide-
lines specified that TTM was indicated in comatose CA
survivors between 18 and 80 years old where professional
cardiopulmonary resuscitation (CPR) was commenced
within 15 min of CA and the return of spontaneous
circulation (ROSC) was achieved within 60 min of CA. The
guidelines further specified that patients with non-cardiac
cause of CA, terminal illness, severe comorbidity, in
need of nursing care on a daily basis or with
coagulopathy should not be offered TTM. The guide-
lines were not strictly enforced, and the ultimate
decision regarding TTM or no TTM was taken by
individual clinicians. This is one of the prerequisites
for propensity score matching, which allowed us to
retain patients with these characteristics in both TTM
and non-TTM groups. The patients considered for in-
clusion in this study were survivors of out-of-hospital
cardiac arrest (OHCA) who were available for TTM
in the emergency department of Haukeland University
Hospital between December 2003 and December 2008.
Patients with a Glasgow Coma Score (GCS) > 8 and patients
with coagulopathy or terminal illness were excluded (Fig. 1).
Intervention
TTM was induced using axillary and femoral ice bags
before hospital admission, and cold saline after admis-
sion, until invasive TTM was established. The CoolGard
Temperature Management System with ICY Catheters
(Zoll Medical Corporation, MA, USA) was used for
invasive TTM. Patients were cooled to 33 °C at a rate of
0.5 °C per hour and maintained at 33 °C for 24 h before
rewarming at a rate of 0.5 °C per hour to 37 °C. Seven
patients included in the intervention group received
surface cooling because invasive cooling was unavailable.
Fig. 1 Flowchart presenting included and excluded patients
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In these seven patients, TTM was established using ac-
tive cooling garments in five patients, ice bags and cold
towels in one patient and ice bags alone in one patient.
Outcome
The primary outcome was restricted mean survival time,
defined as the number of days alive from CA until death
limited to a maximum of 365 days after CA. The sec-
ondary outcome was cerebral function measured by the
cerebral performance category (CPC) scale upon hospital
discharge, a scale from 1 to 5, where 1 is good recovery
and 5 is death [7]. CPC was scored retrospectively by
registrars based on information in the medical records.
No criteria existed regarding the withdrawal of life-
sustaining therapy.
Statistics
Patients were identified and data was collected retro-
spectively from local quality databases and medical re-
cords between 2009 and 2011. Data was stored in a
restricted access database. Initial comparisons between
treatment groups were performed using t-tests for
continuous variables and chi-squared test for discrete
variables. All baseline variables affecting both treatment
and outcome are potential confounders and were con-
sidered for inclusion in the propensity score model. Due
to the small dataset, variables only weakly associated
with outcome were excluded [8]. Potential confounders
included were age, gender, shockable primary rhythm,
witnessed CA, bystander CPR, time from CA to profes-
sional CPR, time from CA to ROSC, smoking status,
known diabetes mellitus, known hypertension and previ-
ous myocardial infarction. Because of low counts in
some categories, smoking was recoded from four to
three categories and hypertension from three to two
categories. Time from CA to ROSC was winsorised to
60 min (i.e. longer times were replaced by 60 min).
For predictors with less than 10 missing values, the
observations with missing data were discarded. For
continuous predictors with more than 10 missing values,
missing values were replaced by fixed values and indica-
tor variables for ‘missing’ were included in the model.
For categorical predictors with more than 10 missing
values, ‘missing’ was treated as a separate category [9, 10].
See Fig. 1 for a flowchart of the data used.
The propensity score was modelled using logistic re-
gression. To ensure that the model was flexible enough
to accurately predict treatment, we used second-degree
Fig. 2 Distribution of propensity scores between TTM-treated patients and controls
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polynomial terms for all three continuous variables. The
distribution of the propensity score in the treatment
groups was examined to ensure adequate overlap (Fig. 2).
Balance checks were based on examining means, pro-
portions and distributions of predictors before and after
matching (Table 3) [8].
Non-treated subjects were matched 1:1 to treated sub-
jects within callipers, using a best-first (‘greedy’) algo-
rithm. The calliper width for matching was set to 10% of
the standard deviation of the logit of the propensity
score since the common rule of 20% did not adequately
balance the predictors.
Survival was compared using mean values restricted to
a maximum of 365 days [11]. The treatment effect was
estimated using a linear mixed-effects model with a ran-
dom intercept for each matching pair. For comparison
purposes, we also report the results from a naïve t-test
(ignoring any confounders), and from an ordinary least
squares model, where we adjust for confounders by
including the same predictors in the same form as in the
propensity score model.
Stata SE version 14.0 (StataCorp LP, Texas, USA) and
R version 3.2.3 with the ‘nonrandom’ package version
1.42 were used for data analysis [12, 13].
Results
A total of 403 comatose CA patients were available for
TTM in the study period. Exclusions due to study cri-
teria numbered 57, while exclusions due to missing data
numbered 10 (Fig. 1). This left 336 patients eligible for
inclusion in the propensity score model, 183 (54%) of
them TTM-treated cases and 153 non-TTM controls. A
crude comparison between treated cases and controls re-
vealed significant differences in age, gender, primary
rhythm, presumed cause of arrest, resuscitation and
medical history (Tables 1 and 2). The propensity score
model developed to balance these differences satisfied
the overlap assumption, i.e. treated cases and controls
with similar propensity scores were available for
matching. We successfully matched 96 treated cases
with controls. The propensity scores had similar distri-
butions in cases and controls after matching, and most
baseline covariates were sufficiently matched (Fig. 2,
Table 2, Additional file 1: Table S5). This indicates that
the propensity score model was adequately specified and
suited for causal inference. The estimation of treatment
effects revealed that survival in the first year after CA
(restricted mean comparison) increased by 57 days (95%
CI: 12–103, p = 0.01) in TTM-treated cases. The mean
CPC value at discharge was reduced by 0.5 (95% CI:
0.1–1.0, p = 0.02) in TTM-treated cases (Table 3).
Discussion
The propensity score analysis shows that intensive care
treatment with TTM compared to intensive care treat-
ment without TTM significantly increased the restricted
mean survival by 57 days (95% CI: 12–103) during the
first year after CA.
Table 1 Demographic and medical characteristics among study patients before matching
Control (n = 153) Treated (n = 183)
Count/[Mean] Percenta/(SD) Count/[Mean] Percenta/(SD) P-value
Mean age [years] with (95% CI) [64] (20) [59] (16) 0.01
Male gender 86/153 56% 140/183 77% <0.001
Primary shockable rhythm 41/143 29% 132/181 73% <0.001
Medical history
Previous myocardial infarction 42/153 27% 52/183 28% 0.94
Heart failure 26/116 22% 25/179 14% 0.086
Hypertension 48/126 38% 62/178 35% 0.64
Lung disease 37/119 31% 32/181 18% 0.01
Diabetes 25/122 20% 25/180 14% 0.17
Kidney disease 13/118 11% 4/179 2% <0.001
Malignancy 16/135 12% 9/178 5% 0.047
Smoke 65/97 67% 113/152 74% 0.27
Hypercholesterolemia 19/67 28% 33/154 21% 0.35
Presumed cause of arrest
Acute myocardial infarction 43/153 28% 104/183 57% <0.001
Previous myocardial infarction 7/153 5% 24/183 13% 0.01
Other heart disease 6/153 4% 10/183 5% 0.69
aThe percentage values are based on patients with non-missing data
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Table 2 Distribution of potential confounders before and after matching
Before matching After matching
Control (n = 153) Treated (n = 183) Control (n = 96) Treated (n = 96)
Count/ Percenta/ Count/ Percenta/ Count/ Percenta/ Count/ Percenta/
[mean] (SD) [mean] (SD) P-value [mean] (SD) [mean] (SD) P-value
Age [64] (20) [59] (16) 0.01 [63] (18) [61] (17) 0.63
Male Gender 86 56% 140 77% <0.001 59 61% 70 73% 0.12
Shockable rhythm <0.001 0.09
No 102 67% 49 27% 56 58% 41 43%
Yes 41 27% 132 72% 38 40% 53 55%
(Missing) 10 7% 2 1% 2 2% 2 2%
Witnessed CA 111 73% 164 90% <0.001 76 79% 80 83% 0.58
Bystander CPR 72 47% 130 71% <0.001 52 54% 56 58% 0.66
Time CA to professional CPR [14.6] (25.5) [11.2] (16.8) 0.15 [7.1] (5.6) [8.0] (5.5) 0.32
(Missing) 12 8% 6 3% 0.11 6 6% 6 6% 1.00
Time CA to ROSC [27.2] (16.5) [26.7] (16.1) 0.77 [24.4] (13.8) [22.7] (12.6) 0.38
(Missing) 9 6% 16 9% 0.43 6 6% 8 8% 0.78
Smoking 0.001 0.44
No 32 21% 39 21% 23 24% 18 19%
Ex-smoker 28 18% 47 26% 19 20% 19 20%
Smoker 37 24% 66 36% 27 28% 37 39%
(Missing) 56 37% 31 17% 27 28% 22 23%
Diabetes Mellitus <0.001 0.69
No 97 63% 155 85% 73 76% 79 82%
Type 1 5 3% 5 3% 4 4% 2 2%
Type 2 20 13% 20 11% 16 17% 12 12%
(Missing) 31 20% 3 2% 3 3% 3 3%
Hypertension <0.001 0.83
No 78 51% 116 63% 56 58% 57 59%
Yes 48 31% 62 34% 33 34% 34 35%
(Missing) 27 18% 5 3% 7 7% 5 5%
Previous myocardial infarction 42 27% 52 28% 0.94 30 31% 29 30% 1.00
SD standard deviation, CA cardiac arrest, CPR cardiopulmonary resuscitation, ROSC return of spontaneous circulation
aThe percentage values are based on patients with non-missing data
Table 3 Estimated restricted mean survival after cardiac arrest, and estimated mean CPC score after discharge
TTM treated cases Non-TTM controls Difference P-value
n Mean n Mean Mean 95% CI
Survival time (days)
Crude 183 199 153 69 131 97 to 164 <0.001
Propensity-score matched 96 142 96 84 57 12 to 103 0.01
Regression-adjusted 183 – 153 – 52 14 to 91 0.008
CPC score
Crude 183 3.0 151 4.4 −1.3 −1.7 to −1.0 <0.001
Propensity-score matcheda 95 3.7 95 4.2 −0.5 −1.0 to −0.1 0.02
Regression-adjusted 183 – 151 – −0.5 −0.9 to −0.1 0.01
aCPC data was missing for one observation in one of the matched pairs. The pair was excluded from the analysis
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The important question is whether the increase in sur-
vival is due to TTM or due to bias. The data in this
study were collected at a time when new technology was
introduced. As with all observational studies designed
this way, bias is probable. Patients with a better progno-
sis may have been selected for TTM more frequently
than patients with a worse prognosis, and withdrawal of
care may have been more aggressive in patients not se-
lected for TTM. An important aspect of this study is the
introduction of propensity score methodology in order
to reduce bias and establish causality. While not often
used in CA research, the method is common in epidemio-
logic research. Moreover, the method may prove valuable
in the analysis of the large quantity of data accumulating
in various CA registries.
Propensity score methodology reduces bias by using
two important mechanisms. First, the overlap assump-
tion must be fulfilled. This means that there must be a
sufficient number of patients with the same probability
of treatment in both the treatment and the control
group. The propensity score assigned to each individual
in the sample is the estimated probability of treatment
given the baseline covariates. The second mechanism is
balance checks of the baseline covariates. Propensity
score methodology states that all variables which are
measured before allocation of treatment and which
affect both treatment and outcome, i.e. all variables
which are possible confounders, must be included in the
propensity score model. The balance analysis checks that
these variables are distributed equally between TTM and
non-TTM groups [8]. We have included a comprehen-
sive list of possible confounders. Although the balance
in our matched sample is not perfect, any differences are
small, and this greatly reduces any bias the confounders
might introduce to the estimation of treatment effect
(Table 2). Therefore, we believe that the majority of the
estimated treatment effect is due to TTM rather than
confounding.
Restricted mean survival time was chosen as the
primary outcome instead of the commonly used hazard
ratio. The hazard ratio measure relies on the assumption
of proportional hazards, i.e. it assumes a constant hazard
ratio over time. The advantage of the restricted mean
survival time is that it measures survival over the entire
period from inclusion to follow-up, and does not depend
on the proportional hazards assumption [11].
We decided prior to the analysis that follow-up of
1 year would be reasonable in CA. Survival beyond this
point is probably more dependent on factors unrelated
to CA than on the effects of CA. Treatment by TTM in-
creased survival by an estimated 57 days during the first
year after CA. This is a significant difference in a robust
outcome measure. An impression of the magnitude of
the difference can be gained from a study comparing the
restricted mean survival time to hazard ratios in well-
known cancer studies [14]. The hazard ratios in the
RE01 trial in advanced kidney cancer, the GOG111 trial
in advanced ovarian cancer and the IPASS trial in lung
Table 4 Distribution of treatment characteristics among study patients before matching
Control (n = 153) Treated (n = 183)
Count Percent Count Percent P-value
Ice bags prior to admission 15 10% 176 96% <0.001
Cold saline after admission 1 1% 168 92% <0.001
Intensive care treatment
Sedative drugs 71/135 53% 172/172 100% <0.001
Muscle relaxant drugs 6/153 4% 133/183 73% <0.001
Antiepileptic drugs 5/153 3% 51/183 28% <0.001
Dialysis 0/153 0% 4/183 2% 0.18
Fig. 3 Distribution of time in various temperature zones in TTM-treated patients
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cancer were 0.73/0.75/0.73, respectively. Restricted mean
survival times in the same three studies were 0.9 months/
3 months/9 months, respectively. This indicates that the
increase in restricted mean survival time of 57 days in our
study is clinically significant.
The effect of TTM on cognition has been debated
[15]. Our analysis shows a mean reduction in the CPC
score of 0.5 points (95% CI: 0.1–1.0) for TTM-treated
cases upon hospital discharge. When interpreting this
result, it should be borne in mind that death is scored as
five on the CPC. Since TTM-treated cases have better
survival than non-TTM controls, it is likely that part of
the reduction in the CPC score is due to improved
survival. Further studies are needed to ascertain the
effect of TTM on brain function in CA survivors [16].
A total of 15 control patients had axillary and femoral
ice bags placed prior to admission, and one control
patient received infusions with cold saline after admission
(Table 4). This may have influenced the estimation of
treatment effects. However, a recent study of patients with
out-of-hospital CA found no effect on survival or neuro-
logic recovery of pre-hospital induction of TTM using
cold saline versus standard induction after admission [17].
Stringent criteria for inclusion and exclusion in our
study, combined with clearly defined outcome measures
and robust statistical methods, are the main strengths of
the study. However, this cannot outweigh the limitations
of a retrospective observational design [18]. Selection
bias may be hidden among unmeasured baseline covari-
ates not included in our data. We also had to use a
narrow calliper in order to ensure comparable groups.
This reduces the number of cases available for matching
and thus reduces the generalisability of the results. The
matching did not completely balance the covariates
(Table 2), indicating some probability of residual con-
founding. However, any bias in the estimated treatment
effect should be greatly reduced compared to a crude
analysis. Since new treatment was introduced in a non-
blinded fashion, it is likely that TTM patients were
assigned better trained and more dedicated personnel. It
is also probable that TTM patients were given extra
attention in other aspects of their treatment, spurred by
the introduction of new technology. Data on body
temperature are limited, and restricted to the treatment
group (Fig. 3). As a result, no per-protocol analysis was
possible, and nor do we know to what extent fever was
present. The neurological outcome (CPC) was scored in
a non-blinded fashion. In essence, residual confounding
is likely, and we must assume that some of the estimated
treatment effect is due to other factors than the assigned
treatment.
However, survival increased well beyond the level of
significance in a relatively small sample. Our interpret-
ation of the result is that TTM in fact did increase
survival for comatose OHCA patients in our hospital be-
tween December 2003 and December 2008. Interestingly,
our hospital was also part of the recent randomised TTM
study, which found no difference between TTM at 33 and
36 °C in patients enrolled between November 2010 and
January 2013 [4]. An explanation for this might be that
TTM is of importance only when brain resuscitation is
marginal, i.e. when cerebral perfusion pressures are low
and blood glucose and blood gas values are abnormal. A
review of intensive care treatment from historical TTM
patients compared with present TTM patients could
uncover if this is the case.
Conclusions
The study shows that intensive care treatment including
TTM increased survival for unresponsive CA patients
compared to intensive care treatment without TTM in
our hospital.
Additional file
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